Genomic Health Inc (NASDAQ:GHDX)

32.78
Delayed Data
As of Feb 23
 +1.38 / +4.39%
Today’s Change
26.54
Today|||52-Week Range
37.50
-4.15%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Genomic Health Inc have a median target of 32.50, with a high estimate of 42.00 and a low estimate of 25.00. The median estimate represents a -0.85% decrease from the last price of 32.78.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in Genomic Health Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.07
Sales
$89.0M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 208.58%
 
 
 
 
 
 
Growthannually 78.05%
 
 
 
 
 
 

Sales

Growthquarterly 6.16%
 
 
 
 
 
 
Growthannually 4.45%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.